T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Cisco
CSCO
$476B
| $1.9B | 0.4% |
66,305,682
+5,191,284
| +8% | +$146M |
|
52
PepsiCo
PEP
$189B
| $1.89B | 0.4% |
17,869,316
+3,063,246
| +21% | +$316M |
|
|
AMTD
53
DELISTED
TD Ameritrade Holding Corp
AMTD
| $1.88B | 0.4% |
65,973,394
+5,929,440
| +10% | +$180M |
|
|
CELG
54
DELISTED
Celgene Corp
CELG
| $1.85B | 0.39% |
18,753,716
-3,044,808
| -14% | -$315M |
|
55
State Street
STT
$51.4B
| $1.83B | 0.39% |
33,942,936
+3,220,985
| +10% | +$192M |
|
56
O'Reilly Automotive
ORLY
$75.2B
| $1.81B | 0.38% |
99,918,270
-1,969,020
| -2% | -$34.8M |
|
57
MGM Resorts International
MGM
$11.1B
| $1.8B | 0.38% |
79,414,187
-273,397
| -0.3% | -$6.21M |
|
58
Hilton Worldwide
HLT
$71B
| $1.77B | 0.38% |
26,228,819
+534,067
| +2% | +$35M |
|
|
TYC
59
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $1.77B | 0.38% |
39,679,949
-3,045,373
| -7% | -$128M |
|
60
Dollar General
DG
$26.5B
| $1.73B | 0.37% |
18,390,155
+3,300,735
| +22% | +$285M |
|
61
T-Mobile US
TMUS
$192B
| $1.67B | 0.35% |
38,605,424
-962,455
| -2% | -$39.5M |
|
62
Starbucks
SBUX
$122B
| $1.58B | 0.34% |
27,695,581
-2,767,851
| -9% | -$157M |
|
|
HBI
63
DELISTED
Hanesbrands
HBI
| $1.57B | 0.33% |
62,630,517
+1,221,642
| +2% | +$33.3M |
|
64
Tractor Supply
TSCO
$18.4B
| $1.55B | 0.33% |
84,968,780
+6,601,740
| +8% | +$123M |
|
65
Biogen
BIIB
$30.4B
| $1.54B | 0.33% |
6,366,152
-1,753,757
| -22% | -$462M |
|
66
VeriSign
VRSN
$26.3B
| $1.5B | 0.32% |
17,359,429
-719,070
| -4% | -$62M |
|
67
Cigna
CI
$71.7B
| $1.5B | 0.32% |
11,715,995
-2,332,142
| -17% | -$308M |
|
68
Zoetis
ZTS
$31.1B
| $1.47B | 0.31% |
31,056,867
+10,688,777
| +52% | +$505M |
|
69
Agilent Technologies
A
$42.3B
| $1.45B | 0.31% |
32,786,318
+18,097
| +0.1% | +$780K |
|
|
70
Mondelez International
MDLZ
$78.7B
| $1.43B | 0.3% |
31,496,593
+19,294,386
| +158% | +$841M |
|
71
ServiceNow
NOW
$132B
| $1.42B | 0.3% |
106,915,415
+617,860
| +0.6% | +$8.59M |
|
72
Tyson Foods
TSN
$19.9B
| $1.42B | 0.3% |
21,205,222
-2,688,368
| -11% | -$174M |
|
73
Marriott International
MAR
$91.2B
| $1.41B | 0.3% |
21,207,601
+2,118,207
| +11% | +$142M |
|
|
74
Gilead Sciences
GILD
$169B
| $1.4B | 0.3% |
16,755,680
-10,327,901
| -38% | -$917M |
|
75
Verizon
VZ
$196B
| $1.4B | 0.3% |
24,983,693
-489,809
| -2% | -$25.4M |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.